Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.13B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.18B |
| 3 |
Apple
AAPL
|
+$836M |
| 4 |
Alibaba
BABA
|
+$807M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$566M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$429M |
| 2 |
Boeing
BA
|
+$402M |
| 3 |
Coty
COTY
|
+$284M |
| 4 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$104M |
| 5 |
Qualcomm
QCOM
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 89.12% |
| 2 | Technology | 2.44% |
| 3 | Consumer Discretionary | 1.83% |
| 4 | Communication Services | 1.72% |
| 5 | Financials | 1.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Alaunos Therapeutics
TCRT
$4.22M
| $6.11M | ﹤0.01% |
6,990
-1,093
| -14% | -$752K |
|
2427
PUT
Supernus Pharmaceuticals
SUPN
$2.57B
| $6.11M | ﹤0.01% |
184,500
-25,600
| -12% | -$877K |
|
2428
PUT
PVH
PVH
$3.51B
| $6.1M | ﹤0.01% |
64,500
-84,700
| -57% | -$9.37M |
|
2429
PUT
Flex
FLEX
$42.6B
| $6.1M | ﹤0.01% |
845,830
+681,945
| +416% | +$5.25M |
|
2430
CALL
Vanguard Information Technology ETF
VGT
$150B
| $6.09M | ﹤0.01% |
231,200
-180,000
| -44% | -$4.64M |
|
2431
PUT
ING
ING
$100B
| $6.09M | ﹤0.01% |
526,600
+52,000
| +11% | +$620K |
|
2432
PUT
Barclays
BCS
$90.3B
| $6.09M | ﹤0.01% |
817,388
+222,191
| +37% | +$1.76M |
|
2433
PUT
Madrigal Pharmaceuticals
MDGL
$12.6B
| $6.09M | ﹤0.01% |
58,100
-28,900
| -33% | -$3.1M |
|
|
JNPR
2434
PUT
DELISTED
Juniper Networks
JNPR
| $6.09M | ﹤0.01% |
228,600
+8,700
| +4% | +$233K |
|
|
BPY
2435
PUT
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $6.09M | ﹤0.01% |
321,500
-57,600
| -15% | -$1.15M |
|
2436
PUT
Canadian Imperial Bank of Commerce
CM
$104B
| $6.07M | ﹤0.01% |
154,600
+97,400
| +170% | +$3.92M |
|
2437
CALL
Euronet Worldwide
EEFT
$2.56B
| $6.07M | ﹤0.01% |
36,100
-1,300
| -3% | -$199K |
|
2438
CALL
Huntington Ingalls Industries
HII
$11.7B
| $6.07M | ﹤0.01% |
27,000
-23,100
| -46% | -$4.95M |
|
2439
PUT
AnaptysBio
ANAB
$1.7B
| $6.07M | ﹤0.01% |
107,500
+34,500
| +47% | +$2.48M |
|
2440
PUT
Packaging Corp of America
PKG
$21.7B
| $6.05M | ﹤0.01% |
63,500
+7,300
| +13% | +$704K |
|
2441
CALL
TG Therapeutics
TGTX
$8.53B
| $6.05M | ﹤0.01% |
699,600
+81,300
| +13% | +$615K |
|
|
FINV
2442
FinVolution Group
FINV
$949M
| $6.05M | ﹤0.01% |
1,389,738
+15,756
| +1% | +$77.6K |
|
|
EBIX
2443
DELISTED
Ebix Inc
EBIX
| $6.04M | ﹤0.01% |
+120,306
| New | +$5.98M |
|
2444
PUT
Enphase Energy
ENPH
$5.19B
| $6.04M | ﹤0.01% |
331,100
+24,400
| +8% | +$336K |
|
2445
PUT
Hormel Foods
HRL
$11.7B
| $6.03M | ﹤0.01% |
148,800
+51,300
| +53% | +$2.08M |
|
2446
CALL
CrowdStrike
CRWD
$233B
| $6.02M | ﹤0.01% |
+352,800
| New | +$6M |
|
|
NLSN
2447
CALL
DELISTED
Nielsen Holdings plc
NLSN
| $6.02M | ﹤0.01% |
266,400
+51,900
| +24% | +$1.25M |
|
|
EMBJ
2448
CALL
Embraer S.A. ADS
EMBJ
$13.4B
| $6.01M | ﹤0.01% |
298,600
+123,800
| +71% | +$2.39M |
|
2449
PUT
EPAM Systems
EPAM
$5.82B
| $6.01M | ﹤0.01% |
34,700
+6,400
| +23% | +$1.1M |
|
2450
CALL
Axsome Therapeutics
AXSM
$10.8B
| $6M | ﹤0.01% |
233,200
+111,200
| +91% | +$2.23M |
|
Similar funds
Jeff Yass's Q2 2019 Portfolio in Review
As of Q2 2019, Jeff Yass held 11,369 positions worth $275B, up 13% from $243B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass deployed $17.9B of net new capital in Q2 2019, opening 2,651 new positions and adding to 3,766 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 14,345,542 shares worth $4.2B.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Walt Disney, an estimated $429M trimmed.
- Jeff Yass's largest Q2 2019 buy was State Street SPDR S&P 500 ETF Trust: 14,345,542 shares worth $4.2B.
- Jeff Yass added most to Alphabet (Google) Class A in Q2 2019, an estimated $1.18B increase.
- Jeff Yass's biggest Q2 2019 reduction was Walt Disney, cutting an estimated $429M.
- Jeff Yass fully exited Goldcorp Inc in Q2 2019, selling an estimated $26.4M.
- Jeff Yass's ten largest holdings make up 24% of its $275B portfolio in Q2 2019.
- Jeff Yass opened 2,651 new positions and closed 1,221 in Q2 2019.
- Jeff Yass's portfolio value rose 13% quarter-over-quarter to $275B.
Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.